U.S. Department of Defense Awards $5.1 Million to Humanetics Corporation for Continued Development of Radiation Countermeasure View more
BlueAllele® Corporation Continues to Advance Therapeutic Approaches Using Novel Gene Correction Technologies and Secures Third Patent from the USPTO View more
